It has been shown that prostate-specific membrane antigen (PSMA) has potential for the management of prostate cancer chemoprevention by phytochemicals which is emerging as a potential adjunctive approach for the treatment of early carcinogenic processes (27). Here, FOLH1 is linked to Familial prostate cancer.